IMMUNOMAGNETIC REDUCTION FOR FETAL FIBRONECTIN DETECTION | A NOVEL METHOD TO DETECT THE PRETERM BIOMARKER
暂无分享,去创建一个
Chia-Chen Chang | Chii-Wann Lin | Chii-Wann Lin | Shieh-Yueh Yang | Chen-Yu Chen | Chia-Chen Chang | Chun Yu | Shieh-Yueh Yang | Chen-Yu Chen | Chun Yu
[1] G. Lockitch,et al. Fetal fibronectin improves the accuracy of diagnosis of preterm labor. , 1995, American journal of obstetrics and gynecology.
[2] Shieh-Yueh Yang,et al. Hyper-high-sensitivity wash-free magnetoreduction assay on biomolecules using high- Tc superconducting quantum interference devices , 2008 .
[3] John Clarke,et al. Magnetic gradiometer based on a high-transition temperature superconducting quantum interference device for improved sensitivity of a biosensor , 2002 .
[4] K. Titani,et al. The oncofetal structure of human fibronectin defined by monoclonal antibody FDC-6. Unique structural requirement for the antigenic specificity provided by a glycosylhexapeptide. , 1988, The Journal of biological chemistry.
[5] M. Dombrowski,et al. The preterm prediction study: quantitative fetal fibronectin values and the prediction of spontaneous preterm birth. The National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. , 2000, American journal of obstetrics and gynecology.
[6] M. Dombrowski,et al. The Preterm Prediction Study: association between cervical interleukin 6 concentration and spontaneous preterm birth. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. , 2001, American journal of obstetrics and gynecology.
[7] C. Gale,et al. Prevention of age related macular degeneration , 2002, BMJ : British Medical Journal.
[8] M MAYER,et al. [The prevention of premature birth]. , 1953, La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris.
[9] T. Garite,et al. Fetal fibronectin detection as a predictor of preterm birth in actual clinical practice. , 2000, American journal of obstetrics and gynecology.
[10] R. H. Holbrook,et al. Fetal fibronectin as a predictor of preterm birth in patients with symptoms: a multicenter trial. , 1997, American journal of obstetrics and gynecology.
[11] Bo Jacobsson,et al. Monocyte chemotactic protein-1 in cervical and amniotic fluid: relationship to microbial invasion of the amniotic cavity, intra-amniotic inflammation, and preterm delivery. , 2003, American journal of obstetrics and gynecology.
[12] Keiji Enpuku,et al. Detection of Magnetic Nanoparticles with Superconducting Quantum Interference Device (SQUID) Magnetometer and Application to Immunoassays , 1999 .
[13] U. Nicolini,et al. Cervical phIGFBP‐1 in the evaluation of the risk of preterm delivery , 2007, Acta obstetricia et gynecologica Scandinavica.
[14] F. Arechavaleta-Velasco,et al. Vaginal Matrix Metalloproteinase Levels in Pregnant Women With Bacterial Vaginosis , 2006, The Journal of the Society for Gynecologic Investigation: JSGI.
[15] Chin-Yih Hong,et al. Wash-free, antibody-assisted magnetoreduction assays of orchid viruses. , 2008, Journal of virological methods.
[16] H. C. Yang,et al. Biofunctionalized magnetic nanoparticles for high-sensitivity immunomagnetic detection of human C-reactive protein , 2006 .
[17] R. Goldenberg,et al. Biochemical markers for the prediction of preterm birth. , 2005, American journal of obstetrics and gynecology.
[18] Philip Steer,et al. The epidemiology of preterm labor – a global perspective , 2005, Journal of perinatal medicine.
[19] R. Goldenberg,et al. Vaginal Fetal Fibronectin Levels and Spontaneous Preterm Birth in Symptomatic Women , 2001, Obstetrics and gynecology.
[20] S. Hakomori,et al. The oncofetal domain of fibronectin defined by monoclonal antibody FDC-6: its presence in fibronectins from fetal and tumor tissues and its absence in those from normal adult tissues and plasma. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[21] J K Todd,et al. Bacterial protease-induced reduction of chorioamniotic membrane strength and elasticity. , 1987, Obstetrics and gynecology.
[22] Shieh-Yueh Yang,et al. Magnetic susceptibility reduction method for magnetically labeled immunoassay , 2006 .
[23] R L Berkowitz,et al. The presence of cervical and vaginal fetal fibronectin predicts preterm delivery in an inner-city obstetric population. , 1993, American journal of obstetrics and gynecology.
[24] Roberto Romero,et al. Epidemiology and causes of preterm birth , 2008, The Lancet.
[25] Lutz Trahms,et al. Determination of the binding reaction between avidin and biotin by relaxation measurements of magnetic nanoparticles , 1999 .
[26] Shieh-Yueh Yang,et al. Magnetic relaxation measurement in immunoassay using high-transition-temperature superconducting quantum interference device system , 2006 .
[27] C. Y. Yang,et al. Magnetically enhanced high-specificity virus detection using bio-activated magnetic nanoparticles with antibodies as labeling markers. , 2010, Journal of virological methods.
[28] D. Rouse,et al. Prevention of premature birth. , 1998, The New England journal of medicine.
[29] D. Ingbar,et al. An in vitro model for polymorphonuclear-leukocyte-induced injury to an extracellular matrix. Relative contribution of oxidants and elastase to fibronectin release from amnionic membranes. , 1986, The American review of respiratory disease.
[30] Lucas M Bachmann,et al. Accuracy of cervicovaginal fetal fibronectin test in predicting risk of spontaneous preterm birth: systematic review , 2002, BMJ : British Medical Journal.
[31] A. Fanaroff,et al. Outcomes of children of extremely low birthweight and gestational age in the 1990's. , 1999, Early human development.